Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Only Congress can repeal parts of the Inflation Reduction Act that now lets Medicare negotiate drug prices. Still, some are ...

Transparency in the program is more than just a mechanism for fair pricing—it is a driving force that diminishes the returns ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...

Under legislation passed in 2022 called the Inflation Reduction Act, Medicare was allowed for the first time to negotiate prices with drug companies on a limited number of medications.

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Medicare announced plans to negotiate lower prices for 15 costly drugs, including Ozempic, Wegovy, and Trelegy Ellipta, ...